Pascal Minne insider trades: Lexicon Pharmaceuticals (LXRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Pascal reports to the SEC
and 2 more companies
Open-market buys and sales
29 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 16, 2020 | LXRX | ↑ Buy | 10,937,500 | $3.20 | $35.0M | Indirect | Dec 17, 2020 (1d) |
| Dec 8, 2020 | SEER | ↑ Buy | 790,000 | $19.00 | $15.0M | Direct | Dec 10, 2020 (2d) |
| Nov 3, 2020 | SQZ | ↑ Buy | 465,000 | $16.00 | $7.4M | Direct | Nov 3, 2020 (0d) |
| Jun 16, 2020 | GBIO | ↑ Buy | 800,000 | $19.00 | $15.2M | Direct | Jun 18, 2020 (2d) |
| Aug 14, 2018 | WTW | ↓ Sell | 6,000,000 | $76.00 | $456.0M | Indirect | Aug 16, 2018 (2d) |
| Jun 28, 2018 | LXRX | ↑ Buy | 182,838 | $12.51 | $2.3M | Indirect | Jun 29, 2018 (1d) |
| Jun 25, 2018 | LXRX | ↑ Buy | 253,725 | $12.99 | $3.3M | Indirect | Jun 26, 2018 (1d) |
| Jun 21, 2018 | LXRX | ↑ Buy | 72,973 | $13.29 | $970K | Indirect | Jun 21, 2018 (0d) |
| Jun 18, 2018 | LXRX | ↑ Buy | 45,784 | $12.98 | $594K | Indirect | Jun 18, 2018 (0d) |
| Jun 12, 2018 | LXRX | ↑ Buy | 235,396 | $12.80 | $3.0M | Indirect | Jun 12, 2018 (0d) |
| Jun 7, 2018 | LXRX | ↑ Buy | 325,639 | $12.58 | $4.1M | Indirect | Jun 7, 2018 (0d) |
| Jun 4, 2018 | LXRX | ↑ Buy | 416,481 | $12.01 | $5.0M | Indirect | Jun 4, 2018 (0d) |
| May 30, 2018 | LXRX | ↑ Buy | 433,378 | $9.94 | $4.3M | Indirect | May 30, 2018 (0d) |
| May 29, 2018 | SRRK | ↑ Buy | 450,000 | $14.00 | $6.3M | Indirect | May 31, 2018 (2d) |
| May 15, 2018 | WTW | ↓ Sell | 8,625,000 | $66.24 | $571.3M | Indirect | May 17, 2018 (2d) |
| Nov 17, 2017 | LXRX | ↑ Buy | 180,727 | $10.11 | $1.8M | Indirect | Nov 17, 2017 (0d) |
| Nov 14, 2017 | LXRX | ↑ Buy | 575,946 | $9.64 | $5.6M | Indirect | Nov 14, 2017 (0d) |
| Sep 16, 2016 | BUFF | ↓ Sell | 12,512,124 | $24.83 | $310.6M | Direct | Sep 16, 2016 (0d) |
| Jul 5, 2016 | BUFF | ↓ Sell | 15,014,548 | $21.29 | $319.6M | Direct | Jul 7, 2016 (2d) |
| Jul 27, 2015 | BUFF | ↓ Sell | 28,464,603 | $20.00 | $569.3M | Direct | Jul 27, 2015 (0d) |
| Nov 26, 2014 | LXRX | ↑ Buy | 149,253,731 | $1.00 | $150.0M | Indirect | Nov 26, 2014 (0d) |
| Aug 15, 2014 | WTW | ↑ Buy | 51,790 | $23.36 | $1.2M | Indirect | Aug 19, 2014 (4d) |
| Aug 14, 2014 | WTW | ↑ Buy | 126,620 | $23.03 | $2.9M | Indirect | Aug 14, 2014 (0d) |
| Aug 11, 2014 | WTW | ↑ Buy | 257,960 | $22.69 | $5.9M | Indirect | Aug 11, 2014 (0d) |
| Aug 6, 2014 | WTW | ↑ Buy | 257,841 | $21.59 | $5.6M | Indirect | Aug 6, 2014 (0d) |
| Oct 23, 2012 | LXRX | ↑ Buy | 3,000,000 | $2.25 | $6.8M | Indirect | Oct 25, 2012 (2d) |
| Apr 9, 2012 | WTW | ↓ Sell | 9,498,804 | $82.00 | $778.9M | By Artal Holdings Sp. z o.o., Succursale | Apr 11, 2012 (2d) |
| May 26, 2011 | WTW | ↓ Sell | 3,000,000 | $83.66 | $251.0M | By Artal Holdings Sp. z o.o., Succursale | May 31, 2011 (5d) |
| Feb 24, 2011 | WTW | ↓ Sell | 2,000,000 | $60.75 | $121.5M | By Artal Holdings Sp. z o.o., Succursale | Feb 28, 2011 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LXRX insiders
Open-market trades in the last 12 months
About Pascal Minne's insider trades
Pascal Minne is a director at Lexicon Pharmaceuticals (LXRX). Since Feb 24, 2011, Pascal has reported 21 open-market purchases worth $282.2M and 8 sales worth $3.38B on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include conversions (4 filings), other transactions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LXRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.